ISR

IsoRay, Inc.

0.3400
USD
-11.83%
0.3400
USD
-11.83%
0.1922 0.5100
52 weeks
52 weeks

Mkt Cap 48.25M

Shares Out 141.92M

Chat
Send me real-time posts from this site at my email

IsoRay GAAP EPS of -$0.01 in-line, revenue of $2.51M misses by $0.33M

Revenue of $2.51M (-7.4% Y/Y) misses by $0.33M. Cash, cash equivalents, and certificates of deposit at the end of the fiscal year ended June 30, 2022 totaled $55.9 million and the company had no long-term debt. Stockholders’ equity at the end of the fiscal year ended June 30, 2022 totaled $61.3 million. Entered into a definitive agreement to acquire Viewpoint Molecular Targeting.

Welcome! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue